The simulation indicated that the minimum numbers of subjects and samples required to satisfy the criteria for bioequivalence and comparability studies were as follows : fewest for the area under the serum concentration-time curve , more for the area under the efficacy-time curve , and most for the maximum serum concentration of erythropoietin .